Our preliminary study using a dose of 100, 200 or 400 nmol/kg of HSA-Trx clearly indicated that HSA-Trx had a renoprotective effect against a glycerol-induced AKI mouse and that the effect was dose-dependent (data not shown). The gene discussed is TXN; the disease is acute kidney injury.